StockNews.com assumed coverage on shares of Arch Biopartners (NYSE:ARCH – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the stock.
Arch Biopartners Stock Performance
Shares of ARCH stock opened at $134.83 on Thursday. Arch Biopartners has a 1 year low of $116.44 and a 1 year high of $180.65.
Institutional Investors Weigh In On Arch Biopartners
An institutional investor recently bought a new position in Arch Biopartners stock. Total Clarity Wealth Management Inc. acquired a new stake in shares of Arch Biopartners Inc. (NYSE:ARCH – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 329 shares of the company’s stock, valued at approximately $47,000.
Featured Articles
- Five stocks we like better than Arch Biopartners
- Bank Stocks – Best Bank Stocks to Invest In
- Markets Think Robinhood Earnings Could Send the Stock Up
- How to Capture the Benefits of Dividend Increases
- Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
